Neonatal Nursing Certification Review: Cardiac Section 12.1 – CHF & Other Cardiac Medications (1/2)

🚨 MASTER neonatal congestive heart failure and pharmacologic management for certification success and advanced NICU care! Essential for recognizing cardiac decompensation and applying targeted therapies with safety and precision.

👶 This presentation explains the pathophysiology, causes, and management of neonatal CHF. It details fetal versus neonatal etiologies, clinical manifestations, and pharmacologic strategies—focusing on diuretics, ACE inhibitors, and adjunct medications that improve function while minimizing risk.

🎯 HIGH-YIELD EXAM CONTENT
✅ CHF definition, timing, and neonatal presentation
✅ Fetal and neonatal etiologies: shunts, obstruction, myocarditis, anemia
✅ Management priorities—optimize oxygen delivery, nutrition, and pharmacologic balance
✅ Loop diuretics (furosemide): mechanism, dosing, ototoxicity risk
✅ Thiazides and spironolactone: sequential nephron blockade and potassium-sparing synergy
✅ ACE inhibitors (captopril, enalapril): afterload reduction, cardioprotective effects
✅ Monitoring: electrolytes, renal function, blood pressure, and growth
✅ Contraindications and complications of pharmacotherapy in preterm infants

👍 LIKE if this strengthened your neonatal cardiac pharmacology knowledge
💬 COMMENT your most challenging CHF medication management scenario
🔔 SUBSCRIBE for more neonatal certification review modules

#NeonatalNursing #NeonatalCHF #HeartFailure #NICU #CardiacMedications #Diuretics #ACEInhibitors #Captopril #Enalapril #Furosemide #Spironolactone #Hydrochlorothiazide #CertificationPrep #NNPExam #CCRN #RNCNIC #HighYield #NeonatalCardiology #CriticalCare